ArticleEuropean journal of clinical pharmacology2016
Concomitant administration of rifampicin and oxcarbazepine results in a significant decrease of the active MHD metabolite of oxcarbazepine.
Ali Sigaroudi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.